Atlas Trials

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Clinical trial NCT03363659 · TERMINATED

Trial details

NCT number
NCT03363659
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
GlioblastomaGlioblastoma Multiforme
Start date
2018-03-28
Primary completion
2022-01-13
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.